Tetra Bio-Pharma Inc.

OTCPK:TBPM.Q Stock Report

Market Cap: US$515.0

Tetra Bio-Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Guy Chamberland

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.6yrs
CEO ownershipn/a
Management average tenure4.2yrs
Board average tenure7.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Guy Chamberland's remuneration changed compared to Tetra Bio-Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Aug 31 2022n/an/a

-CA$39m

May 31 2022n/an/a

-CA$41m

Feb 28 2022n/an/a

-CA$45m

Nov 30 2021CA$437kCA$325k

-CA$52m

Aug 31 2021n/an/a

-CA$29m

May 31 2021n/an/a

-CA$28m

Feb 28 2021n/an/a

-CA$25m

Nov 30 2020CA$472kCA$298k

-CA$21m

Aug 31 2020n/an/a

-CA$17m

May 31 2020n/an/a

-CA$15m

Feb 29 2020n/an/a

-CA$14m

Nov 30 2019CA$295kCA$214k

-CA$13m

Aug 31 2019n/an/a

-CA$14m

May 31 2019n/an/a

-CA$10m

Feb 28 2019n/an/a

-CA$10m

Nov 30 2018CA$263kCA$191k

-CA$8m

Aug 31 2018n/an/a

-CA$5m

May 31 2018n/an/a

-CA$8m

Feb 28 2018n/an/a

-CA$7m

Nov 30 2017CA$153kCA$153k

-CA$6m

Compensation vs Market: Insufficient data to establish whether Guy's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Guy's compensation with company performance.


CEO

Guy Chamberland (62 yo)

6.6yrs

Tenure

CA$436,642

Compensation

Dr. Guy Chamberland, M.Sc., Ph D., Master Herbalist, has been the Chief Executive Officer and Chief Regulatory Officer at Tetra Bio-Pharma Inc. since October 15, 2018 and serves as its Director since June...


Leadership Team

NamePositionTenureCompensationOwnership
Guy Chamberland
Co-Founder6.6yrsCA$436.64kno data
Steeve Néron
Chief Commercial Officer4.2yrsCA$313.61kno data
André Rancourt
Co-Founderno datano datano data
Leslie Auld
Chief Financial Officer2.5yrsno datano data
Jennifer McCaughey
Vice President of Investor Relationsno datano datano data
Dania Scott
Senior Vice President of Commercial Strategy4.2yrsno datano data
Aurelia Pauw
Senior VP of Clinical Programs & Medical Affairs3.8yrsno datano data
Richard Giguere
Chief Executive Officer of Tetra Natural Health Inc.6.1yrsno datano data
Randy Ringuette
Project Director & Member of Advisory Boardno datano datano data
Chris MacLean
Chief Operating Officer of Tetra Natural Health5.5yrsno datano data

4.2yrs

Average Tenure

Experienced Management: TBPM.Q's management team is considered experienced (4.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Guy Chamberland
Co-Founder5.4yrsCA$436.64kno data
Randy Ringuette
Project Director & Member of Advisory Board9yrsno datano data
Catherine Auld
Independent Director3.5yrsCA$56.76kno data
Steven Edgett
Member of Strategic Advisor4.3yrsno datano data
Brent Norton
Independent Chairman4.2yrsCA$151.76kno data
Adam Greenblatt
Member of Advisory Board9yrsno datano data
Erin Prosk
Member of Advisory Board9yrsno datano data
Charles Campbell
Member of Advisory Board9yrsno datano data
Louis-Philippe de Lorimier
Member of Clinical Advisory Board7.2yrsno datano data
Cheryl Cullen
Member of Clinical Advisory Board7.1yrsno datano data
Aubrey Webb
Member of Clinical Advisory Board7.1yrsno datano data
John Kim
Independent Director3.5yrsCA$56.76kno data

7.1yrs

Average Tenure

62yo

Average Age

Experienced Board: TBPM.Q's board of directors are considered experienced (7.1 years average tenure).